恩华药业(002262.SZ)发布前三季度业绩，归母净利润11.06亿元，同比增长8.42%

Core Insights - Enhua Pharmaceutical (002262.SZ) reported a revenue of 4.471 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 7.85% [1] - The net profit attributable to shareholders of the listed company reached 1.106 billion yuan, with a year-on-year increase of 8.42% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 1.109 billion yuan, reflecting a year-on-year growth of 7.59% [1]